Evidence in humans suggests that SIRT1-mediated pathways aided in resolving NAFLD by increasing NAD + in the liver, but knockdown of SIRT3 does not change liver status38. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.